Evaluation of microRNA Gene Polymorphisms in Liver Transplant Patients with Hepatocellular Carcinoma

被引:1
|
作者
Dehbidi, Sahar [1 ]
Farokhizadeh, Zhaleh [1 ]
Karimi, Mohammad Hossein [2 ]
Afshari, Afsoon [2 ]
Behmanesh, Mehrdad [3 ]
Sanati, Mohammad Hossein [4 ]
Geramizadeh, Bita [2 ]
Yaghobi, Ramin [2 ]
机构
[1] Nour Danesh Inst Higher Educ, Fac Biol Sci, Dept Biol, Esfahan, Iran
[2] Shiraz Univ Med Sci, Shiraz Transplant Res Ctr, Shiraz, Iran
[3] Tarbiat Modares Univ, Fac Biol Sci, Dept Genet, Tehran, Iran
[4] Natl Inst Genet Engn & Biotechnol, Dept Med Genet, Tehran, Iran
关键词
Hepatocellular Carcinoma; MicroRNA; Liver Transplantation; Rejection; Polymorphism; TURKISH POPULATION; FUNCTIONAL POLYMORPHISM; EXPRESSION PATTERNS; HUMAN CANCER; ASSOCIATION; RISK; INFECTION; SUSCEPTIBILITY; MIR-499A-GREATER-THAN-G; CONTRIBUTES;
D O I
10.5812/hepatmon.102690
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Genetic polymorphism in the miRNA sequence might alter miRNA expression and/or maturation, which is associated with the development and progression of hepatocellular carcinoma (HCC) in liver transplant patients. Objectives: Therefore, the prevalence of miRNA-146a G > C (rs2910164), miRNA-499A > G (rs3746444), miRNA-149C > T (rs2292832), and miRNA-196a-2 C > T (rs11614913) gene polymorphisms was evaluated in liver recipients with HCC with or without experiencing graft rejection. Methods: In a cross-sectional study, tissue samples were collected from 60 HCC patients who underwent liver transplant surgery at Namazi Hospital, Shiraz, Iran, in 2013 - 2015. A control group consisting of 120 individuals was randomly selected, as well. The genomic DNA was extracted from collected tissues and blood samples. The miRNA-146a (rs2910164), miRNA-499 (rs3746444), miRNA-149 (rs2292832), and miRNA-196a-2 (rs11614913) gene polymorphisms were evaluated in patients with HCC using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Results: The CC genotype and C allele of the miRNA-146a (rs2910164) polymorphism were significantly associated with the increased risk of transplant rejection in patients with HCC (P = 0.05 and P = 0.05, respectively). The CC genotype and C allele of the miRNA-146a (rs2910164) were also significantly more frequent in male liver transplant patients who experienced acute rejection than in non-rejected ones (P = 0.05 and P = 0.03, respectively). However, no significant association was found between the genotypes and alleles of miRNA-499 (rs3746444), miRNA-149 (rs2292832), and miRNA-196a-2 (rs11614913) polymorphisms and HCC outcomes in liver transplant recipients. Conclusions: The importance of the CC genotype and C allele of the miRNA-146a (rs2910164) polymorphism in increasing the risk of transplant rejection was confirmed, but it needs further studies in larger populations.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 50 条
  • [21] Immunotherapy Use Prior to Liver Transplant in Patients with Hepatocellular Carcinoma
    Woo, Stephanie M.
    Kimchy, Alexandra V.
    Sequeira, Lynette M.
    Dorris, Charles S.
    He, Aiwu R.
    Rangnekar, Amol S.
    CURRENT ONCOLOGY, 2022, 29 (12) : 9813 - 9825
  • [22] ASSOCIATION OF GENETIC POLYMORPHISMS OF MICRORNA WITH RISK OF HEPATOCELLULAR CARCINOMA
    Hwang, Seong Gyu
    Kim, Wonhee
    Rim, Kyu Sung
    Lee, Jung Min
    Hong, Sung Pyo
    Park, Pil Won
    Ko, Kwang Hyun
    Kwon, Chang-Il
    Kwon, Sung Won
    Kim, Kook-Hyun
    HEPATOLOGY, 2010, 52 (04) : 1189A - 1190A
  • [23] Association of MicroRNA Polymorphisms With Hepatocellular Carcinoma in an Iranian Population
    Farokhizadeh, Zhaleh
    Dehbidi, Sahar
    Geramizadeh, Bita
    Yaghobi, Ramin
    Malekhosseini, Seyed Ali
    Behmanesh, Mehrdad
    Sanati, Mohammad Hossein
    Afshari, Afsoon
    Moravej, Ali
    Karimi, Mohammad Hossein
    ANNALS OF LABORATORY MEDICINE, 2019, 39 (01) : 58 - 66
  • [24] MDR1 gene polymorphisms and risk of recurrence in patients with hepatocellular carcinoma after liver transplantation
    Wu, Liming
    Xu, Xiaobu
    Shen, Juwei
    Xie, Haiyang
    Yu, Songfeng
    Hang, Tingbo
    Wang, Weilin
    Shen, Yan
    Zhang, Min
    Zheng, Shusen
    JOURNAL OF SURGICAL ONCOLOGY, 2007, 96 (01) : 62 - 68
  • [25] Review on liver transplant for hepatocellular carcinoma
    Chiao, Hellen
    Yang, Chao-Hsiung Edward
    Frenette, Catherine T.
    TRANSLATIONAL CANCER RESEARCH, 2013, 2 (06) : 472 - 481
  • [26] Model of Urgency for Liver Transplantation in Hepatocellular Carcinoma: A Practical Model to Prioritize Patients With Hepatocellular Carcinoma on the Liver Transplant Waitlist
    Norman, Joshua S.
    Mehta, Neil
    Kim, W. Ray
    Liang, Jane W.
    Biggins, Scott W.
    Asrani, Sumeet K.
    Heimbach, Julie
    Charu, Vivek
    Kwong, Allison J.
    GASTROENTEROLOGY, 2025, 168 (04)
  • [27] Association of two common microRNA gene polymorphisms with risk of hepatocellular carcinoma: a meta-analysis
    Zhu, Shao-Liang
    Gong, Wen-Feng
    Han, Chuang-Ye
    Li, Hang
    Li, Le-Qun
    Zhong, Jian-Hong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02): : 535 - 543
  • [28] MicroRNA-196A-2 Polymorphisms and Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
    Kim, Hwi Young
    Yoon, Jung-Hwan
    Lee, Hyo-Suk
    Cheong, Jae Youn
    Cho, Sung Won
    Shin, Hyoung Doo
    Kim, Yoon Jun
    JOURNAL OF MEDICAL VIROLOGY, 2014, 86 (03) : 446 - 453
  • [29] Evaluation of the Intention-to-Treat Benefit of Living Donation in Patients With Hepatocellular Carcinoma Awaiting a Liver Transplant
    Lai, Quirino
    Sapisochin, Gonzalo
    Gorgen, Andre
    Vitale, Alessandro
    Halazun, Karim J.
    Iesari, Samuele
    Schaefer, Benedikt
    Bhangui, Prashant
    Mennini, Gianluca
    Wong, Tiffany C. L.
    Uemoto, Shinji
    Lin, Chih-Che
    Mittler, Jens
    Ikegami, Toru
    Yang, Zhe
    Frigo, Anna Chiara
    Zheng, Shu-Sen
    Soejima, Yuji
    Hoppe-Lotichius, Maria
    Chen, Chao-Long
    Kaido, Toshimi
    Lo, Chung Mau
    Rossi, Massimo
    Soin, Arvinder Singh
    Finkenstedt, Armin
    Emond, Jean C.
    Cillo, Umberto
    Lerut, Jan Paul
    JAMA SURGERY, 2021, 156 (09)
  • [30] Durvalumab and tremelimumab for hepatocellular carcinoma in patients listed for a liver transplant.
    Sohal, Davendra
    Moreland, Katie
    Quillin, Ralph
    Lemon, Kristina
    Rojan, Adam
    Olowokure, Olugbenga Olanrele
    Shah, Shimul
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : TPS638 - TPS638